Mind Medicine (MindMed) Inc. (MNMD) has a consensus analyst rating of Buy, based on 1 analyst covering the stock. Of those, 1 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for MNMD is $16.00, representing a -22.7% downside from the current price of $20.69. Price targets range from a low of $16.00 to a high of $16.00.
